Learn more about the use of mHealth technology
in the mental health space
Peter Hagelund discusses how Monsenso’s mHealth solution has helped his psychiatrist diagnose his Bipolar Disorder Type 2 more quickly and accurately, helping him avoid further months of anxiety and confusion.
“Monsenso helps me to maintain balance between manic and depressive episodes.” Mads Trier-Blom’s Customer Story
In this video, Monsenso user Mads Trier-Blom speaks of his experience using the Monsenso app as a part of a clinical trial. The Monsenso app helped him to become more aware of his mood, and other factors, such as sleep, and their influence on his bipolar affective disorder.
In this video, Monsenso User Peter Hagelund speaks about his experience using our mobile health solution to support his bipolar disorder treatment, and how the solution has helped improve and inform his communication with his psychiatrist.
Monsenso provides medication adherence and behavioural monitoring components in H2020 Funded R-LiNK Study
Monsenso is participating in R-LiNK, the major new study for developing a more complete understanding of the reactions and effects of taking lithium. Monsenso is now involved in more than ten pan European and domestic research projects in the mental health & affective disorders field.
Clinical observations suggest that changes in speech features have been suggested as valid measures, to identify periods of depression and mania in bipolar disorder. For instance, reduced speech activity may be considered a symptom of depression, and increased speech activity may predict a switch to hypomania.
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. People suffering from bipolar disorder will have periods or episodes of depression – where they feel very low and lethargic mania – where they feel high and overactive.